Safety and Efficacy Data for Mobocertinib in Patients with mNSCLC

Video

Dr Jason Porter presents safety and efficacy data from a Phase 1/2 study on mobocertinib in patients with mNSCLC.

Related Videos
Experts on breast cancer
Expert on GVHD
Expert on breast cancer
Experts on breast cancer
Expert on GVHD
Experts on GVHD
Expert on breast cancer
Experts on breast cancer
Expert on GVHD
Expert on GVHD
Related Content